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Abstract
Background: Structural requirements for the β 1 integrin functions in cell adhesion, spreading and
signaling have been well documented mainly for fibroblasts. In this study, we examined the reason
for the reduced surface expression of β 1 integrin in human breast cancer MCF-7 cells compared
to normal human breast epithelial (HBE) cells, both of which adhered to collagen type IV.
Results: The β 1 integrin immunoprecipitates from either HBE or MCF-7 cells involved α -actinin
while actin coprecipitated with β 1 integrin from HBE cells but not from MCF-7 cells.
Immunoblotting using the anti-phosphotyrosine (PY) antibody indicated the phosphorylation of β 1
integrin at least at tyrosine in both cells. Dephosphorylation of β 1 integrin from HBE cells by
protein tyrosine phosphatase (PTP), but not by protein serine/threonine phosphatase (PP), caused
dissociation of actin from β 1 integrin, although dephosphorylation of it from MCF-7 cells by either
PTP or PP caused association of the two proteins. In MCF-7 cells β 1 integrin coprecipitated doublet
of proteins having the Ca2+/calmodulin-dependent protein kinase (CaMK) II activity that was
susceptible to KN-62, a specific inhibitor of CaMKII.
Conclusion: The results suggest that β 1 integrin is tyrosine phosphorylated and links with actin
via α -actinin in HBE cells but prevented from linking with actin in MCF-7 cells by phosphorylation
at both tyrosine and serine/threonine of β 1 integrin which forms a complex with α -actinin and
CaMKII. Thus the linkage formation of β 1 integrin with actin may be differentially regulated by its
tyrosine and serine/threonine phosphorylation in normal HBE cells and breast cancer MCF-7 cells.
Background
The integrin family of surface receptors play a critical
role in many cellular processes that include cell adhe-
sion, cell spreading, and growth signaling [1–6]. In-
tegrins interact extracellularly with the substratum such
as collagens at specific sites called focal adhesions and
intracellularly with many actin-binding proteins such as
α -actinin, talin, and vinculin, thereby linking these pro-
teins with the actin cytoskeleton. Links between cell sur-
face receptor β  integrins and the actin cytoskeleton are
though to be established in more than one way. Integrin
binds to talin [7], which also binds to vinculin [8–10],
which in turn binds to α -actinin [11,12], which then binds
to actin. This constitutes a three-protein link between in-
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tegrin and actin. In addition, talin can also bind actin di-
rectly [13,14], so that talin may form a direct one-protein
link between integrin and actin. Similarly, the actin-
binding protein α -actinin binds to the β 1 integrin subu-
nit [15]. While many isoforms of β 1 integrin have been
reported [16,17], a short cytoplasmic domain of 47 amino
acids of β 1 integrin isoform A contains the three putative
domains with the highest affinity for α -actinin [18]. In
addition, several amino acids and motifs within the cyto-
plasmic domain of the β  subunit, which are potential
phosphorylation sites, have been implicated in the in-
tegrin function. The β 1 subunit contains a Val-Thr-Thr
sequence and these two threonines appear to be impor-
tant for adhesion of fibroblast cells [19], and adhesion
and invasion of lymphoid cells [20]. However, the rele-
vance of phosphorylation of these amino acids within the
cytoplasmic domain of β 1 integrin in its function remains
largely unclear.
Human breast cancer MCF-7 cells have many cellular
properties characteristic to malignantly transformed
cells; such as an enhanced growth ability in soft agar and
poor cell adhesion to the substatum compared to their
normal counterpart HBE cells [21]. Poor cell adhesion of
MCF-7 cells to the substratum is thought to be mainly
caused by a low level of β 1 integrin expression on the cell
surface [21]. This observation gave a clue to further un-
derstanding the relevance of β 1 integrin function to cell
adhesion, cell spreading, and anchorage-independent
growth in cancerous cells. In this study, we examined
why only a small population of β 1 integrin present in
MCF-7 cells is expressed on the cell surface compared to
HBE cells, both of which adhere to collagen type IV. Im-
munoprecipitation and Western blot analysis revealed
that intracellular linkage between β 1 integrin and actin
formed in HBE cells was lost in MCF-7 cells. The rele-
vance of phosphorylation of β 1 integrin to its linkage
forming ability with actin was also examined in this
study using PTP and PP.
Results
The absence of coprecipitation of actin with β 1 integrin in 
MCF-7 cells
To determine whether expression of β 1 integrin on the
cell surface requires its intracellular interaction with the
actin cytoskeleton, β 1 integrin was immunoprecipitated
with the anti-β 1 integrin antibody or control IgG from
HBE or MCF-7 cells which adhered to collagen IV. West-
ern blot analysis revealed that actin coprecipitated with
β 1 integrin but not with the IgG precipitates from quies-
cent HBE cells (Fig. 1A). In contrast, actin did not copre-
cipitate with β 1 integrin or the IgG precipitates from
adherent MCF-7 cells (Fig. 1A). To determine whether
the failure to coprecipitate actin with β 1 integrin was due
to the absence of actin expression, whole cell lysates were
prepared from HBE or MCF-7 cells, both of which were
quiescent and adherent to collagen IV. Immunoblot
analysis indicated that total amounts of actin and β 1 in-
tegrin were comparable between HBE and MCF-7 cells
(Fig. 1B).
α -Actinin-mediated interaction between β 1 integrin and 
actin
Interaction between β 1 integrin and the actin cytoskele-
ton is mediated by the actin-binding proteins which are
involved in the focal adhesion complex where integrin β 1
through its cytoplasmic domain links with the actin cy-
toskeleton. We next determined which actin-binding
proteins mediate this linkage between β 1 integrin and ac-
tin. Immunoblot analysis of the β 1 integrin or control
IgG precipitates for α -actinin, talin and vinculin, re-
vealed that only α -actinin among three proteins copre-
cipitated with β 1 integrin but not with the IgG
precipitates from quiescent HBE cells (Fig. 2A). Similar
to HBE cells, α -actinin, but not talin or vinculin, copre-
cipitated with β 1 integrin but not with the IgG precipi-
tates from quiescent MCF-7 cells (Fig. 2A). Western
blotting for the whole cell lysates revealed that total
amounts of α -actinin and vinculin in HBE and MCF-7
cells were comparable and that the amount of talin was
slightly smaller in MCF-7 cells than that in HBE cells
(Fig. 2B). The results indicated that α -actinin coprecipi-
tated with β 1 integrin in both HBE and MCF-7 cells.
Expression of the wild-type integrin β 1A in both HBE and 
MCF-7 cells
The cytoplasmic domain of β 1 integrin is short and has
the putative binding domains for α -actinin [18]. To de-
termine the difference in the cytoplasmic domain of β 1
integrin between HBE and MCF-7 cells, total RNA was
extracted from the cells and the cDNA that covers the
full-length of the cytoplasmic domain of β 1 integrin was
amplified. Reverse transcription-polymerase chain reac-
tion (RT-PCR) products from HBE or MCF-7 cells were
identical in lengh with 462-bp on agarose gels (Fig. 3A).
Sequence analysis of the cDNA fragments of HBE and
MCF-7 cells revealed that both fragments were identical
to the wild-type cytoplasmic domain of β 1 integrin iso-
form A (Fig. 3B), indicating that there is no difference in
the cytoplasmic domain of β 1 integrin between HBE and
MCF-7 cells.
The phosphorylation state of β 1 integrin
The importance of β 1 integrin phosphorylation to its
functions which include cell adhesion and invasion has
been suggested by many investigations [19,20,22,23]. To
determine this possibility, we examined the phosphor-
ylation state of β 1 integrin in HBE and MCF-7 cells. Met-
abolic labeling of cells with [32P]orthophosphoric acid
indicated that β 1 integrin (110 kDa), and not α -actininBMC Cell Biology 2001, 2:23 http://www.biomedcentral.com/1471-2121/2/23
(100 kDa), was phosphorylated in either HBE and MCF-
7 cells (Fig. 4A). When the β 1 integrin immunoprecipi-
tates were probed with anti-phosphotyrosine (PY) anti-
body, β 1 integrin, and not α -actinin, reacted with the
antibody in both HBE and MCF-7 cells (Fig. 4B). This in-
dicates that β 1 integrin is phosphorylated at least at tyro-
sine in MCF-7 cells as well as in HBE cells.
Effects of dephosphorylation of β 1 integrin on its link with 
actin
To determine the role of phosphorylation of β 1 integrin
in the link formation between β 1 integrin and actin, the
β 1 integrin immunoprecipitates were dephosphorylated
by PTP or PP. Treatment of the β 1 integrin immunopre-
cipitates from HBE cells with PTP resulted in tyrosine
dephosphorylation of β 1 integrin as assessed by the anti-
PY antibody and concomitant dissociation of actin from
it (Fig. 5A). In contrast, tyrosine dephosphorylation of β 1
integrin from MCF-7 cells by PTP did not affect the ab-
sence of coprecipitation of actin with β 1 integrin but suc-
cessive incubation of the PTP-treated β 1 integrin with
the supernatant of the β 1 immunoprecipitates that con-
tained unbound actin or with exogenous human platelet
actin caused coprecipitation of actin with β 1 integrin
(Fig. 5A). The result indicated that β 1 integrin in either
cells was tyrosine phosphorylated. On the other hand,
dephosphorylation of the β 1 integrin immunoprecipi-
tates from either cells by PP2A1 did not result in any al-
teration in coprecipitation of two proteins or the
reactivity of β 1 integrin with the anti-PY antibody (Fig.
5B). Actin remained coprecipitated with β 1 integrin from
HBE cells, while it remained dissociated from β 1 integrin
from MCF-7 cells. However, incubation of the PP2A1-
treated β 1 integrin from MCF-7 cells with the superna-
tant of the β 1 immunoprecipitates or with exogenous hu-
man platelet actin caused coprecipitation of actin with β 1
integrin (Fig. 5B). The results indicated that β 1 integrin
in HBE cells is not serine/threonine phosphorylated but
in MCF-7 cells.
CaMKII binding to β 1 integrin in MCF-7 cells
Loss of linkage between the cell-cell adhesion molecule
E-cadherin and the actin cytoskeleton, that is mediated
by a three-protein link of β -catenin, α -catenin and α -ac-
tinin, is induced by association of the EGF receptor hav-
ing the protein tyrosine kinase activity with β -catenin
that leads to tyrosine phosphorylation of β -catenin and
concomitant dissociation of α -catenin from it [24,25]. By
analogy with this phenomenon, the β 1 integrin immuno-
precipitates were probed with the antibodies to several
serine/threonine protein kinases to determine whether
serine/threonine protein kinase associates with β 1 in-
tegrin. Among these, the anti-CaMKII antibody, which
reacts broadly with all CaMKII isoforms, reacted with
doublet of proteins having molecular mass of around 56
Figure 1
Coprecipitation of actin with β 1 integrin in HBE cells
and not in MCF-7 cells. (A) Integrin β 1 was immunopre-
cipitated (IP) with the anti-β 1 integrin antibody or control
IgG from HBE or MCF-7 cells which were quiescent and
adherent to collagen IV. The immunoprecipitates were
immunoblotted with anti-actin or anti-integrin β 1 mono-
clonal antibody. Molecular size markers are indicated at right
in kDa. (B) Whole cell lysates were prepared from HBE or
MCF-7 cells which were quiescent and adherent to collagen
IV, and equal amounts (5 µ g protein) of the lysates were
resolved by SDS-PAGE and blotted. The blots were probed
with anti-actin or anti-integrin β 1 monoclonal antibody.
Molecular size markers are indicated at right in kDa.BMC Cell Biology 2001, 2:23 http://www.biomedcentral.com/1471-2121/2/23
kDa in the β 1 integrin immunoprecipitates but not in the
control IgG precipitates from MCF-7 cells (Fig. 6A).
These proteins which were reactable with the anti-CaM-
KII antibody were not detected in the β 1 integrin or con-
trol IgG precipitates from HBE cells (Fig. 6A). To
confirm the CaMKII kinase activity of the doublet of pro-
teins, in vitro kinase assay was carried out using a specif-
ic substrate peptide Autocamtide II, in the presence of
calmodulin and inhibitor peptides of cAMP-dependent
protein kinase (PKA) and protein kinase C (PKC).
Whereas the β 1 integrin immunoprecipitates from HBE
cells exhibited a very low level of the kinase activity that
was slightly above that of the precipitates without anti-β 1
integrin antibody, the relative kinase activity of the im-
munoprecipitates from MCF-7 cells was 17-fold (Stu-
dent's t-test, p < 0.01) above that of the β 1 integrin
immunoprecipitates from HBE cells (Fig. 6B). When 10
µM KN-62, a specific inhibitor of CaMKII [26–28], was
present, the kinase activity of the β 1 integrin immuno-
precipitates from HBE cells was 7-fold above (p < 0.05)
that in the absence of KN-62 (Fig. 6B). Contrary to this,
Figure 2
Coprecipitation of α -actinin, but not talin or vinculin, with β 1 integrin in HBE and MCF-7 cells. (A) Integrin β 1
was immunoprecipitated (IP) from HBE and MCF-7 cells using the anti-β 1 integrin antibody or control IgG. The immunoprecip-
itates were probed with anti-α -actinin, anti-talin, or anti-vinculin antibody. Molecular size markers are indicated at right in kDa.
(B) Equal amounts (5 µg protein) of whole cell lysates from quiescent HBE and MCF-7 cells were probed with anti-α -actinin,
anti-talin, or anti-vinculin antibody. Molecular size markers are indicated at right in kDa.BMC Cell Biology 2001, 2:23 http://www.biomedcentral.com/1471-2121/2/23
10 µM KN-62 significantly inhibited the kinase activity of
the β 1 integrin immunoprecipitates from MCF-7 cells by
92% (p < 0.01) (Fig. 6B).
Discussion
Immunoprecipitation and Western blotting revealed
that actin coprecipitated with β 1 integrin from quiescent
HBE cells but not from MCF-7 cells. Coprecipitation of
actin with β 1 integrin but not with the control IgG precip-
itates from HBE cells indicates that association of β 1 in-
tegrin with actin is not non-specific. Since actin
expression in MCF-7 cells adhering to collagen IV was
comparable with that in HBE cells, the result suggests
that loss of linkage between β 1 integrin and the actin cy-
toskeleton in MCF-7 cells may not be due to the absence
of actin expression.
The β 1 integrin subunit interacts by its cytoplasmic do-
main with many actin-binding proteins, such as α -ac-
tinin, talin, and vinculin, thereby forming a link between
β 1 integrin and the actin cytoskeleton [7–12]. Immuno-
precipitation followed by Western blotting revealed that
only α -actinin, but not talin or vinculin, coprecipitated
with β 1 integrin but not with the IgG precipitates from
Figure 3
Amino acid sequence of the cytoplasmic domain of β 1 integrin in HBE or MCF-7 cells. (A) Agarose gel electro-
phoresis of RT-PCR products. Total RNA was extracted from HBE or MCF-7 cells which were quiescent and adherent to col-
lagen IV, and cDNA encoding the cytoplasmic domain of β 1 integrin was amplified by RT-PCR. The cDNA products were
resolved in 1.6% (w/v) agarose gel electrophoresis with molecular size markers (Mr) and stained with etidium bromide. Molec-
ular size of the cDNA products are indicated at right in bp. (B) The cDNA fragments of 462-bp were extracted from agarose
gels and sequence analysis was carried out. Amino acid sequences of the three peptides with the highest affinity for α -actinin
are underlined (adapted from [18]).BMC Cell Biology 2001, 2:23 http://www.biomedcentral.com/1471-2121/2/23
Figure 4
The phosphorylation state of β 1 integrin. (A) HBE or
MCF-7 cells which were quiescent and adherent to collagen
IV were metabolically labeled with [32P]orthophosphoric acid
and β 1 integrin was immunoprecipitated from the cells. After
separation on 8% SDS-PAGE, gels were dried and autoradio-
graphed. Unlabeled samples were electrophoresed and trans-
ferred onto membranes. The blots were probed with
antibodies to β 1 integrin and α -actinin. Molecular size mark-
ers are indicated at right in kDa. (B) Tyrosine phosphoryla-
tion of β 1 integrin in HBE and MCF-7 cells. Integrin β 1 was
immunoprecipitated from HBE or MCF-7 cells and the immu-
noprecipitates were resolved by 8% SDS-PAGE before blot-
ting. The blots were then probed with anti-PY or anti-
integrin β 1 monoclonal antibody. Molecular size markers are
indicated at right in kDa.
Figure 5
Effects of dephosphorylation of β 1 integrin on its
coprecipitation with actin. (A) The β 1 integrin immuno-
precipitates from quiescent HBE or MCF-7 cells were
treated with (+) or without (-) PTP, then immunoblotted
with anti-actin, anti-β 1 integrin, or anti-PY antibody. The
PTP-treated  β 1 integrin immunoprecipitates from MCF-7
cells were incubated for 30 min with (+) or without (-) the
supernatant of the β 1 immunoprecipitates containing
unbound actin (Cell lysate), or with 5 µg/ml exogenous
human platelet actin (A). Molecular size markers are indi-
cated at right in kDa. (B) The β 1 integrin immunoprecipitates
from quiescent HBE or MCF-7 cells were treated with (+) or
without (-) PP2A1, then the PP2A1-treated β 1 integrin from
MCF-7 cells were incubated for 30 min with (+) or without (-
) the supernatant of the β 1 immunoprecipitates (Cell lysate),
or with 5 µg/ml exogenous human platelet actin (A). The
immunoblots were probed with anti-actin, anti-β 1 integrin,
or anti-PY antibody. Molecular size markers are indicated at
right in kDa.BMC Cell Biology 2001, 2:23 http://www.biomedcentral.com/1471-2121/2/23
both HBE and MCF-7 cells. This indicates the specific as-
sociation between α -actinin and β 1 integrin in both HBE
and MCF-7 cells. Whereas comparable amounts of α -ac-
tinin and vinculin are present in HBE and MCF-7 cells
and slightly reduced level of talin is seen in MCF-7 cells,
the result suggests that α -actinin, but not talin or vincu-
lin, may predominantly mediate a one-protein link be-
tween β 1 integrin and actin in both HBE and MCF-7 cells
and that the loss of linkage between the two proteins in
MCF-7 cells may be due to the absence of a link between
β 1 integrin-associated α -actinin and actin.
In spite of the fact that α -actinin may directly bind with
actin [15], structural requirements for the functions of
the cytoplasmic domain of β 1 or β 3 integrin in cell adhe-
sion and cell spreading are strongly suggested by many
investigations [19,20,22,23]. In addition, there are sev-
eral isoforms within the cytoplasmic domain of β 1 in-
tegrin [16,17]. These observations prompted us to
examine which isoform of β 1 integrin is expressed in
MCF-7 cells. RT-PCR, using a set of primers correspond-
ing to the sequences covering the cytoplasmic domain of
β 1 integrin isoform A, demonstrated that the same cDNA
fragments in lengh were amplified from HBE and MCF-
7 cells. Sequence analysis indicated that the cDNA frag-
ments had the identical sequence and corresponded to
sequences encoding the cytoplasmic domain of the wild-
type β 1A integrin. This suggests that both HBE and MCF-
7 cells express the same wild-type β 1 integrin and that
the loss of linkage between β 1 integrin and actin may not
be due to the structural difference in the cytoplasmic do-
main of β 1 integrin in MCF-7 cells from that in HBE cells.
The relevance of phosphorylation of the β  subunit of in-
tegrin at threonine [19,20] or tyrosine residue [23] to the
integrin functions that include cell adhesion and inva-
sion has been documented. Therefore we next examined
the phosphorylation state of β 1 integrin and its relation
to the linkage formation with actin. Metabolic labeling of
cells with [32P]orthophosphoric acid and Western blot-
ting using the anti-PY antibody indicated that β 1 in-
tegrin, but not α -actinin, in either HBE or MCF-7 cells
was phosphorylated at least on a tyrosine residue and
that there was no apparent difference in the phosphor-
ylation state of β 1 integrin between two cells. Therefore,
the susceptibility of the linkage forming ability of β 1 in-
tegrin with actin to PTP or PP was examined. Effects of
the PTP treatment of the β 1 immunoprecipitates from
HBE and MCF-7 cells were contradictory; that is, copre-
cipitation of actin with β 1 integrin from HBE cells was
lost, while that of two proteins from MCF-7 cells was in-
duced after incubation of the PTP-treated immunopre-
cipitates with the supernatant of the immunoprecipitates
or with exogenous human platelet actin. As the reactivity
of anti-PY antibody with β 1 integrin from either HBE or
Figure 6
CaMKII binding to β 1 integrin in MCF-7 cells. (A) The
β 1 integrin immunoprecipitates (IP) with the anti-β 1 integrin
antibody or control IgG from HBE or MCF-7 cells were
probed with antibody to all CaMKII isoforms or anti-β 1
integrin antibody. Molecular size markers are indicated at
right in kDa. (B) The β 1 integrin immunoprecipitates from
HBE or MCF-7 cells were incubated with the substrate pep-
tide Autocamtide II, calmodulin, inhibitor peptides of PKA
and PKC, and [32P]ATP with (closed columns) or without
(open columns) 10 µM KN-62 at 30°C for 10 min. After sub-
traction of the background, the activity was normalized to
the amount of β 1 integrin and expressed relative to that of
the β 1 integrin immunoprecipitates from HBE cells without
KN-62. Results represent the mean ± S.D. (bars) of duplicate
assays of three independent experiments.BMC Cell Biology 2001, 2:23 http://www.biomedcentral.com/1471-2121/2/23
MCF-7 cells was lost by PTP and exogenous actin copre-
cipitated with PTP-treated β 1 integrin from MCF-7 cells,
alterations in coprecipitation of actin with β 1 integrin
may be due to tyrosine dephosphorylation of β 1 integrin
and not other proteins involved in the immunoprecipi-
tates or the supernatant of the immunoprecipitates. In
addition, the result suggests that tyrosine phosphoryla-
tion is necessary for β 1 integrin to link with actin in HBE
cells but inhibitory for it in MCF-7 cells. Contrary to this,
treatment of the β 1 integrin immunoprecipitates with
PP2A1 did not result in any alteration in coprecipitation
of actin with β 1 integrin from HBE cells but caused co-
precipitation of the two proteins from MCF-7 cells. As
PP2A1 did not affect tyrosine phosphorylation of β 1 in-
tegrin from either HBE or MCF-7 cells and exogenous ac-
tin became coprecipitated with PP2A1-treated  β 1
integrin from MCF-7 cells as endogenous actin in the su-
pernatant, the results suggested that PP2A1-induced co-
precipitation of β 1 integrin from MCF-7 cells with actin
may be due to serine/threonine dephosphorylation of β 1
integrin rather than other cellular proteins and that the
ability of β 1 integrin to link with actin in MCF-7 cells may
be prevented by its serine/threonine phosphorylation.
While it appears that phosphorylation at either tyrosine
or serine/threonine is necessary for β 1 integrin to link
with actin and phosphorylation at both tyrosine and ser-
ine/threonine prevents β 1 integrin from linking with ac-
tin, the linkage formation of β 1 integrin with the actin
cytoskeleton may be differentially regulated in MCF-7
cells as compared to HBE cells by tyrosine or serine/
threonine phosphorylation of β 1 integrin.
Finally we examined whether some protein kinases asso-
ciate with β 1 integrin in MCF-7 cells, using antibodies to
several serine/threonine protein kinases. Among these,
the anti-CaMKII antibody reacted with doublet of pro-
teins with molecular mass of around 56 kDa which co-
precipitated with β 1 integrin from MCF-7 cells but not
from HBE cells. As the antibody to CaMKII did not react
with any protein in the control IgG precipitates from
MCF-7 cells, association of the doublet of proteins with
β 1 integrin may be specific. The results demonstrating
that the β 1 integrin immunoprecipitates from MCF-7
cells had the kinase activity for a specific substrate pep-
tide, Autocamtide II, under the conditions where cal-
modulin and inhibitor peptides of PKA and PKC were
present and that this kinase activity was completely in-
hibited by 10 µM KN-62, a specific inhibitor of CaMKII
[26–28], suggest that the doublet of proteins which asso-
ciate with β 1 integrin in MCF-7 cells may be CaMKII iso-
forms. Even though the reason for an elevated level of the
kinase activity of the β 1 immunoprecipitates from HBE
cells by KN-62 is unknown at present, it is possible to as-
sume that some unidentified protein kinases which are
responsive to KN-62 may associate with β 1 integrin in
HBE cells. Coprecipitation of CaMKII with β 1 integrin in
MCF-7 cells does not imply their direct association. As
direct association between CaMKII and α -actinin has
been reported by yeast two-hybrid and biochemical as-
says [29], CaMKII in MCF-7 cells may bind to α -actinin,
which may also bind to β 1 integrin, forming a ternary
complex with α -actinin and β 1 integrin. Whether serine/
threonine phosphorylation of β 1 integrin in MCF-7 cells
is regulated by the β 1 integrin-associated CaMKII, or
whether loss of intracellular linkage between β 1 integrin
and the actin cytoskeleton causes the reduced cell sur-
face expression of β 1 integrin, are areas for further inves-
tigation.
Conclusion
Intracellular linkage of β 1 integrin with the actin cy-
toskeleton via α -actinin was formed in HBE cells which
adhered to type IV collagen. However, this linkage was
lost in adherent MCF-7 cells. The present results suggest
that tyrosine phosphorylation may be required for β 1 in-
tegrin to link with actin in HBE cells, but phosphoryla-
tion of β 1 integrin at both tyrosine and serine/threonine
residues in MCF-7 cells may cause dissociation of actin
from it. Thus the linkage formation of β 1 integrin with
the actin cytoskeleton may be differentially regulated by
its tyrosine and serine/threonine phosphorylation in
normal HBE cells and breast cancer MCF-7 cells.
Materials and methods
Cell culture and replating on collagen type IV
HBE cells obtained form Clonetics were maintained in
serum-free defined medium MCDB 170 [30] supple-
mented with 10 ng/ml EGF, 1.4 µM hydrocortisone, 5
µg/ml insulin, 0.1 mM ethanolamine, 0.1 mM phos-
phoethanolamine, and 25 µM prostaglandin E2 [24] at
37° C in a humidified atmosphere of 95% air and 5% CO2.
MCF-7 cells were maintained in 5% fetal bovine serum
(FBS)-containing RPMI 1640 medium. Subconfluent
culture of HBE or MCF-7 cells were harvested with
0.25% (w/v) trypsin-2.65 mM EDTA solution and the
cells were replated on 60-mm collagen IV-coated dishes
(Becton-Dickinson). HBE or MCF-7 cells were then
growth arrested by incubation in an EGF-deprived medi-
um for 3 days or in 0.1% FBS-containing medium for 2
days, respectively.
Immunoprecipitation and Western blot analysis
Cells adherent to collagen type IV were lysed in RIPA
buffer (10 mM Tris-HCl, pH 7.4, 0.15 M NaCl, 1% sodium
deoxycholate, 1% Triton X-100, 0.1% SDS, 1 mM phenyl-
methylsulfonyl fluoride (PMSF), and 1 mM sodium or-
thovanadate) [25] and sonicated briefly using an
ultrasonic cell disruptor (Misonix Inc.). The cell lysates
were incubated with the anti-integrin β 1 monoclonal an-
tibody (Life Technologies) or control IgG followed byBMC Cell Biology 2001, 2:23 http://www.biomedcentral.com/1471-2121/2/23
Protein A-Sepharose (Amersham Pharmacia). The im-
munoprecipitates were washed three times with PB buff-
er (20 mM phosphate buffer, pH 8.6, 0.5% Nonidet P-
40, and 0.1% SDS) and boiled for 2 min in lysis buffer
(0.0625 M Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, and
5% 2-mercaptoethanol). Whole cell lysates were pre-
pared by homogenizing cells in 1% SDS in 20 mM Tris-
HCl, pH 7.4, 1 mM PMSF and 1 mM sodium orthovanad-
ate, and then boiling for 2 min, before sonicating briefly.
The protein content was determined using a protein rea-
gent kit (Pierce) with bovine serum albumin (BSA) as the
standards. The immunoprecipitates or whole cell lysates
were dissolved in SDS-polyacrylamide gel electrophore-
sis (PAGE) and after electrophoresis the samples were
transferred onto membranes (Millipore). The blots were
probed with anti-actin (ICN), anti-β 1 integrin, anti-α -ac-
tinin (Upstate Biotechnology), anti-talin (Chemicon),
anti-vinculin (Sigma), anti-phosphotyrosine (PY) (Up-
state Biotechnology), or anti-CaMKII antibody (Santa
Cruz Biotechnology). After incubation of the membrane
with horseradish peroxidase-conjugated secondary anti-
bodies (Amersham Pharmacia), the reactivity was visual-
ized using an ECL kit (Amersham Pharmacia) and X-ray
films (Fuji-film).
RT-PCR and direct sequencing
Total RNA was extracted from unstimulated cells which
adhered to collagen IV, using TRIzol reagent and then di-
gested with DNase I (Life Technologies). A one-step RT-
PCR was carried out using an RT-PCR kit (CLONTECH)
at the anealing temperature of 55°C. The primer set for
the cytoplasmic domain of β 1A integrin was 5'-TC-
CTATTTTAACATTACCAA-3' and 5'-ACTGTGACTAT-
GGAAATTGC-3' [16]. The PCR products were
electrophoresed on 1.6% (w/v) agarose gels and the
cDNA was extracted from the gel bands. The DNA se-
quence was confirmed for both forward and reverse
strands of cDNA fragments using the set of PCR primers
on an automated DNA sequencer (ABI PRISM 3100, Ap-
plied Biosystems).
Metabolic labeling of cells
Adherent cells to collagen IV-coated dish were labeled
with 100 µCi/ml of [32P]orthophosphoric acid (Amer-
sham Pharmacia) in phosphate-free medium for the last
24 h during incubation to arrest the cells. Immunopre-
cipitation of β 1 integrin and SDS-PAGE of the immuno-
precipitates were carried out as described above. After
electrophoresis, gels were dried under vacuum and auto-
radiographed using X-ray films at -70°C for a weak.
Phosphatase treatment
Immunoprecipitation of β 1 integrin was carried out as
described above and the supernatant obtained by cen-
trifugation of the immunoprecipitates with the Protein
A-Sepharose beads was retained at room temperature.
The β 1 integrin immunoprecipitates were washed twice
with PB buffer and once with phosphatase buffer (50
mM Tris-HCl, pH 7.0, 150 mM NaCl, and 0.1 mM ED-
TA). Then the immunoprecipitates were treated with or
without 1.0 unit of PTP (LAR, Calbiochem) [31–33] for
10 min or 0.1 units of serine/threonine-specific PP
(PP2A1, Calbiochem) [34–36] for 15 min in 100 µl of
phosphatase buffer at 30°C. In some experiments, the
phosphatase-treated immunoprecipitates were washed
with RIPA buffer and incubated with the retained super-
natant of the β 1 immunoprecipitates that contained un-
bound actin or with 5 µg/ml human platelet actin
(Cytoskeleton, Inc.) in RIPA buffer containing 0.2 mM
CaCl2 for 30 min at room temperature.
CaMKII assay
Immunoprecipitation of β 1 integrin was carried out as
described above, and the β 1 integrin immunoprecipitates
were washed twice with PB buffer and once with 20 mM
phosphate-buffered saline, pH 7.2. In vitro kinase assay
for  β 1 integrin-associated CaMKII was carried out at
30°C for 10 min using [γ -32P]ATP (NEN Life Science
Products) and a CaMKII assay kit (Upstate Biotechnolo-
gy) that included specific substrate peptide Autocamtide
II, calmodulin, and inhibitor peptides of PKA and PKC.
In some experiments, the kinase assay was done in the
presence of KN-62 (1-[N,O-Bis(5-isoquinolinesulfo-
nyl)]-N-methyl-L-tyrosyl-4-phenylpiperazine) (Sigma),
a specific inhibitor of CaMKII [26–28] at the indicated
concentrations. The background kinase assay was car-
ried out using the precipitates with the Protein A-Sepha-
rose beads but without the antibody to β 1 integrin.
Radioactivity incorporated into the substrate peptide
was determined with a liquid schintillation counter. Af-
ter subtraction of the background, the activity was nor-
malized to the amount of β 1 integrin that was quantified
by measurement of the band intensity of β 1 integrin on
SDS-PAGE gels using an image analyzer equipped with a
digital camera (EDAS 290, Kodak).
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